It has now come to light that Takeda Pharmaceuticals knew about the cancer risks associated with the ingestion of Actos, a drug they developed to treat type 2 diabetes. However,…
Read More
The first Actos lawsuit has gone to trial in a California Superior Court in Los Angeles, known as Cooper v. Takeda Pharmaceuticals America Inc. Cooper v. Takeda is being heard…
Read More
The second Actos bladder cancer lawsuit is currently on trial in the Circuirt Court for the City of Baltimore. The plaintiffs in the case, the family of Diep An, a…
Read More
Research demonstrates a strong connection between the development of bladder cancer and the use of Actos, a drug prescribed to patients with diabetes. Actos is known generically as pioglitazone, and…
Read More
Testimony provided in late March by a urologist in an Actos trial taking place in a Los Angeles court presented an expert's opinion about the link between Actos and bladder…
Read More
The manufacturer of the diabetes drug Actos, a drug that is tied up in mounting complaints and lawsuits citing the development of bladder cancer, has received U.S. Food and Drug…
Read More
In 2003, Takeda Pharmaceuticals Inc. expressed concerns about whether Actos users could develop cancer. These reservations on the part of the Japanese pharmaceutical company came to light in court documents…
Read More
Takeda Pharmaceuticals, the Japanese pharmaceutical giant responsible for the development and marketing of the diabetes drug Actos, concealed the association between Actos and bladder cancer, a jury was recently told…
Read More
Published November 29, 2012 by PR Web St. Louis, Missouri (PRWEB) November 29, 2012 November is American Diabetes Month and the pharmaceutical product liability lawyers at Carey & Danis are…
Read More
Carey & Danis Actos lawyers were optimistic last week when plaintiff Jack Cooper received a compensatory award in the amount of $6.5 million. However, it appears that California Superior Court…
Read More